Status:
NOT_YET_RECRUITING
Sex-Based Differences of LA: Impact on AF Ablation.
Lead Sponsor:
Centro Medico Teknon
Conditions:
Atrial Fibrillation (AF)
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is to assess sex-related differences in patients who underwent a first ablation procedure for paroxysmal or persistent AF, guided by the personalized ablation strategy of the BY-L...
Eligibility Criteria
Inclusion
- Patients who underwent a first ablation procedure for atrial fibrillation (paroxysmal or persistent).
- Availability of an adequate pre-procedural cardiac CT scan for LAWT, LAV and inFAT analysis.
- Availability of complete procedural data, including ablation index (AI) values recorded using the SmartTouch catheter (Biosense Webster).
- Availability of 12-month follow-up data for efficacy and safety endpoint evaluation.
- Ablation performed according to the by-LAWT protocol
Exclusion
- Age \< 18 years.
- Previous cardiac ablation (including AF ablation or other arrhythmias).
- Incomplete data regarding procedural parameters, or follow-up.
- Poor quality pre-procedural cardiac MDCT
- Ablation not performed according to the BY-LAWT protocol.
- Structural heart disease (e.g., dilated cardiomyopathy, valvular heart disease with surgical indication) that could substantially influence atrial dimensions or ablation response.
Key Trial Info
Start Date :
January 1 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 30 2026
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT07159685
Start Date
January 1 2026
End Date
May 30 2026
Last Update
September 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Teknon Medical center
Barcelona, Spain, 08022